Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
| Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. |
| Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Institutional LLC |
| 1:2019cv01488 |
| August 9, 2019 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 30, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906 B2. (Attachments: #1 Notice of Dismissal)(fms) |
| CASE CLOSED per D.I. #6 . (fms) |
| Filing 6 NOTICE of Voluntary Dismissal by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. as to Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Institutional LLC (without prejudice) (Blumenfeld, Jack) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. (sam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906 B2. (sam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 2, 2019. Date of Expiration of Patent: January 26, 2031.Thirty Month Stay Deadline: 1/2/2022. (sam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Institutional LLC, Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2705242.) - filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(sam) |
| Summons Issued with Magistrate Consent Notice attached as to Mylan Institutional LLC on 8/9/2019; Mylan Laboratories Limited on 8/9/2019; Mylan Pharmaceuticals Inc. on 8/9/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
